We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$8.68B
AUM Growth
+$1.84B
Cap. Flow
+$1.56B
Cap. Flow %
17.92%
Top 10 Hldgs %
52.47%
Holding
92
New
28
Increased
20
Reduced
13
Closed
21

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$309M
2
IQV icon
IQVIA
IQV
+$279M
3
BEAV
B/E Aerospace Inc
BEAV
+$235M
4
V icon
Visa
V
+$213M
5
WWAV
The WhiteWave Foods Company
WWAV
+$198M

Top Sells

Rank Stock Value
1
LNKD
LinkedIn Corporation
LNKD
+$350M
2
IMS
IMS HEALTH HLDGS INC COM STK (DE)
IMS
+$228M
3
ITC
ITC HOLDINGS CORP
ITC
+$180M
4
CTSH icon
Cognizant
CTSH
+$174M
5
TDG icon
TransDigm Group
TDG
+$151M

Sector Composition

Rank Sector Weight
1 Healthcare 18.74%
2 Technology 15.94%
3 Communication Services 13.83%
4 Industrials 5.24%
5 Consumer Staples 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLUB
51
DELISTED
Town Sports International Holdings, Inc.
CLUB
$10.2M 0.12%
4,060,082
– –
ABBV icon
52
AbbVie
ABBV
$433B
$10M 0.12%
+160,000
New +$9.77M
AZN icon
53
AstraZeneca
AZN
$245B
$9.97M 0.11%
+182,500
New +$10.4M
HZNP
54
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9.87M 0.11%
+610,000
New +$11.1M
NVET
55
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$9.72M 0.11%
2,648,696
– –
GILD icon
56
Gilead Sciences
GILD
$163B
$9.67M 0.11%
+135,000
New +$10M
AMRN
57
Amarin Corp
AMRN
$297M
$6.48M 0.07%
105,250
– –
LKFT
58
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
$5.84M 0.07%
+90,955
New +$5.6M
BCE icon
59
BCE
BCE
$20.3B
$5.78M 0.07%
133,650
– –
PCO
60
DELISTED
Pendrell Corporation - Class A
PCO
$5.54M 0.06%
8,211
-328
-4% -$217K
CAB
61
DELISTED
Cabela's Inc
CAB
$4.68M 0.05%
80,000
+40,427
+102% +$2.51M
AKAO
62
DELISTED
Achaogen Inc
AKAO
$4.56M 0.05%
+350,000
New +$2.4M
STML
63
DELISTED
Stemline Therapeutics, Inc.
STML
$2.75M 0.03%
+257,500
New +$3.11M
MITL
64
DELISTED
Mitel Networks Corporation
MITL
$2.63M 0.03%
386,267
– –
GCVRZ
65
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.6M 0.03%
6,827,805
+4,000,000
+141% +$1.35M
ILMN icon
66
Illumina
ILMN
$29.9B
$2.43M 0.03%
+19,532
New +$2.63M
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.24M 0.03%
+100,000
New +$1.95M
KDMN
68
DELISTED
Kadmon Holdings, Inc.
KDMN
$1.43M 0.02%
285,620
– –
ACIU icon
69
AC Immune
ACIU
$226M
– –
-15,000
Closed -$247K
ALSN icon
70
Allison Transmission
ALSN
$9.65B
– –
-3,633,298
Closed -$104M
CI icon
71
Cigna
CI
$74.5B
– –
-115,000
Closed -$15M
CTSH icon
72
Cognizant
CTSH
$24.9B
– –
-3,648,641
Closed -$174M
GD icon
73
General Dynamics
GD
$103B
– –
-822,051
Closed -$128M
KLAC icon
74
KLA
KLAC
$239B
– –
-4,950,000
Closed -$34.5M
MOH icon
75
Molina Healthcare
MOH
$10.2B
– –
-85,000
Closed -$4.96M
1 2
3
4

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Farallon Capital Management held 92 positions worth $8.68B, up 27% from $6.84B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Farallon Capital Management deployed $1.56B of net new capital in Q4 2016, opening 28 new positions and adding to 20 existing holdings. Its largest new stake was IQVIA: 3,634,880 shares worth $276M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was SBA Communications, an estimated $93.7M trimmed.

  • Farallon Capital Management's largest Q4 2016 buy was IQVIA: 3,634,880 shares worth $276M.
  • Farallon Capital Management added most to NXP Semiconductors in Q4 2016, an estimated $309M increase.
  • Farallon Capital Management's biggest Q4 2016 reduction was SBA Communications, cutting an estimated $93.7M.
  • Farallon Capital Management fully exited LinkedIn Corporation in Q4 2016, selling an estimated $350M.
  • Farallon Capital Management's ten largest holdings make up 52% of its $8.68B portfolio in Q4 2016.
  • Farallon Capital Management opened 28 new positions and closed 21 in Q4 2016.
  • Farallon Capital Management's portfolio value rose 27% quarter-over-quarter to $8.68B.

Based on Farallon Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.